Home › Hypoparathyroidism
Hypoparathyroidism clinical trials recruiting in the U.S.
8 studies for Hypoparathyroidism are recruiting participants at sites across the United States.
Cities with the most studies
By state
Recently updated studies
Efficacy, Safety, and Tolerability of Encaleret in Participants With Chronic Hypoparathyroidism
RecruitingPhase 3
Ages 16 and older · All sexes · Updated Nov 12, 2026 · NCT07805356A Phase 3 Randomized Clinical Trial to Investigate the Safety and Efficacy of Palopegteriparatide at Doses Greater Than 30 μg/Day in Adult Participants With Hypoparathyroidism
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT07081997A Study to Investigate Canvuparatide Compared With Placebo in Adult Patients With Hypoparathyroidism
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 29, 2026 · NCT07699471A Study to Assess the Amount of Palopegteriparatide in Breast Milk of Lactating Females Requiring YORVIPATH® (Palopegteriparatide)
RecruitingObservational study
Ages 18 to 50 · Women · Updated Aug 7, 2026 · NCT07264634Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 100 · All sexes · Updated May 7, 2026 · NCT07083557A Global Pregnancy Registry to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to YORVIPATH® (Palopegteriparatide) During Pregnancy and Breastfeeding
RecruitingObservational study
Ages 15 to 50 · Women · Updated Mar 2, 2026 · NCT07345494Parathyroid Allotransplant for Treatment of Hypoparathyroidism
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Feb 27, 2026 · NCT06961071Hypoparathyroidism Natural History Study
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 100 · All sexes · Updated Dec 16, 2025 · NCT05793853From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.